138 related articles for article (PubMed ID: 36518886)
1. Antitumor activity of RUNX3: Upregulation of E-cadherin and downregulation of the epithelial-mesenchymal transition in clear-cell renal cell carcinoma.
Yang RN; Zhou FR; Wang HY; Wang QH; Ji JL; Huang T; Guo C; Dong Z; Cao YW
Open Life Sci; 2022; 17(1):1579-1590. PubMed ID: 36518886
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of homeobox D10 expression suppresses invasion and migration of clear cell renal cell carcinoma through targeting of E-cadherin.
Ren Z; Niu Y; Fan B; Zhang A
Mol Biol Rep; 2022 Mar; 49(3):1837-1846. PubMed ID: 34825321
[TBL] [Abstract][Full Text] [Related]
3. RUNX3 regulates renal cell carcinoma metastasis via targeting miR-6780a-5p/E-cadherin/EMT signaling axis.
Chen F; Liu X; Cheng Q; Zhu S; Bai J; Zheng J
Oncotarget; 2017 Nov; 8(60):101042-101056. PubMed ID: 29254144
[TBL] [Abstract][Full Text] [Related]
4. Demethylation drug 5-Aza-2'-deoxycytidine-induced upregulation of miR-200c inhibits the migration, invasion and epithelial-mesenchymal transition of clear cell renal cell carcinoma
Jiang J; Yi BO; Ding S; Sun J; Cao W; Liu M
Oncol Lett; 2016 May; 11(5):3167-3172. PubMed ID: 27123083
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma.
Liu F; Wu L; Wang A; Xu Y; Luo X; Liu X; Hua Y; Zhang D; Wu S; Lin T; He D; Wei G; Chen S
Am J Transl Res; 2017; 9(8):3611-3622. PubMed ID: 28861152
[TBL] [Abstract][Full Text] [Related]
6. SNX5 suppresses clear cell renal cell carcinoma progression by inducing CD44 internalization and epithelial-to-mesenchymal transition.
Zhou Q; Li J; Ge C; Chen J; Tian W; Tian H
Mol Ther Oncolytics; 2022 Mar; 24():87-100. PubMed ID: 35024436
[TBL] [Abstract][Full Text] [Related]
7. Roles of transcriptional factor Snail and adhesion factor E-cadherin in clear cell renal cell carcinoma.
Cai J
Exp Ther Med; 2013 Dec; 6(6):1489-1493. PubMed ID: 24255679
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
9. KAT7 Suppresses Tumorigenesis in Clear Cell Renal Cell Carcinoma (ccRCC) by Regulating Cell Cycle and Ferroptosis Sensitivity.
Hong G; Chen W; Gong M; Wu Y; Shu G; Xiao Y; Zhang T; ShuXiong X
Exp Cell Res; 2024 Jul; ():114149. PubMed ID: 38960363
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients.
Chen L; Zhu D; Feng J; Zhou Y; Wang Q; Feng H; Zhang J; Jiang J
Cancer Cell Int; 2019; 19():101. PubMed ID: 31015801
[TBL] [Abstract][Full Text] [Related]
11. miR-363 suppresses the proliferation, migration and invasion of clear cell renal cell carcinoma by downregulating S1PR1.
Xie Y; Chen L; Gao Y; Ma X; He W; Zhang Y; Zhang F; Fan Y; Gu L; Li P; Zhang X; Gou X
Cancer Cell Int; 2020; 20():227. PubMed ID: 32536815
[TBL] [Abstract][Full Text] [Related]
12. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
13. Micall2 Is Responsible for the Malignancy of Clear Cell Renal Cell Carcinoma.
Zeng X; Wang H; Yang J; Hu J
Yonago Acta Med; 2023 Feb; 66(1):171-179. PubMed ID: 36811029
[TBL] [Abstract][Full Text] [Related]
14. RUNX3 regulates hepatocellular carcinoma cell metastasis via targeting miR-186/E-cadherin/EMT pathway.
Gou Y; Zhai F; Zhang L; Cui L
Oncotarget; 2017 Sep; 8(37):61475-61486. PubMed ID: 28977878
[TBL] [Abstract][Full Text] [Related]
15. TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma.
Jiang B; Chen W; Qin H; Diao W; Li B; Cao W; Zhang Z; Qi W; Gao J; Chen M; Zhao X; Guo H
Cancer Lett; 2019 May; 449():76-86. PubMed ID: 30772441
[TBL] [Abstract][Full Text] [Related]
16. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
[TBL] [Abstract][Full Text] [Related]
17. RUNX3 regulates vimentin expression via miR-30a during epithelial-mesenchymal transition in gastric cancer cells.
Liu Z; Chen L; Zhang X; Xu X; Xing H; Zhang Y; Li W; Yu H; Zeng J; Jia J
J Cell Mol Med; 2014 Apr; 18(4):610-23. PubMed ID: 24447545
[TBL] [Abstract][Full Text] [Related]
18. DRAM1 plays a tumor suppressor role in clear cell renal cell carcinoma through modulating Akt signaling.
Feng Q; Cheng M; Jin J; Zhang S; Bai Y; Xu J
Acta Histochem; 2022 Apr; 124(3):151874. PubMed ID: 35299128
[TBL] [Abstract][Full Text] [Related]
19. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q
Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919
[TBL] [Abstract][Full Text] [Related]
20. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
